Hetta, H.F.; Melhem, T.; Aljohani, H.M.; Salama, A.; Ahmed, R.; Elfadil, H.; Alanazi, F.E.; Ramadan, Y.N.; Battah, B.; Rottura, M.;
et al. Beyond Conventional Antifungals: Combating Resistance Through Novel Therapeutic Pathways. Pharmaceuticals 2025, 18, 364.
https://doi.org/10.3390/ph18030364
AMA Style
Hetta HF, Melhem T, Aljohani HM, Salama A, Ahmed R, Elfadil H, Alanazi FE, Ramadan YN, Battah B, Rottura M,
et al. Beyond Conventional Antifungals: Combating Resistance Through Novel Therapeutic Pathways. Pharmaceuticals. 2025; 18(3):364.
https://doi.org/10.3390/ph18030364
Chicago/Turabian Style
Hetta, Helal F., Tameem Melhem, Hashim M. Aljohani, Ayman Salama, Rehab Ahmed, Hassabelrasoul Elfadil, Fawaz E. Alanazi, Yasmin N. Ramadan, Basem Battah, Michelangelo Rottura,
and et al. 2025. "Beyond Conventional Antifungals: Combating Resistance Through Novel Therapeutic Pathways" Pharmaceuticals 18, no. 3: 364.
https://doi.org/10.3390/ph18030364
APA Style
Hetta, H. F., Melhem, T., Aljohani, H. M., Salama, A., Ahmed, R., Elfadil, H., Alanazi, F. E., Ramadan, Y. N., Battah, B., Rottura, M., & Donadu, M. G.
(2025). Beyond Conventional Antifungals: Combating Resistance Through Novel Therapeutic Pathways. Pharmaceuticals, 18(3), 364.
https://doi.org/10.3390/ph18030364
